Crown Bioscience and Data Sciences International (DSI) Partner to Advance Metabolic Disease Research Using an ...
(World News USA)

SANTA CLARA, Calif., Nov. 23, 2017 (GLOBE NEWSWIRE) -- Crown Bioscience, a wholly-owned subsidiary of Crown Bioscience International (TWSE: ticker 6554) and a global drug discovery and development services company providing translational platforms to advance oncology, inflammation cardiovascular and metabolic disease research, announces the successful development of an enhanced method for preclinical obesity and type 2 diabetes studies in partnership with Data Sciences International (DSI). Crown Bioscience´s clinically relevant models and DSI´s HD-XG implantable glucose device combine to create a superior approach to preclinical metabolic disease research. ......